← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2007Last known activity
Feb 28, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 7 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT06763666CollaboratorPhase 4Feb 28, 2025
- NCT06758609Sponsor investigatorN/ADec 1, 2024
- NCT06758609Lead sponsorN/ADec 1, 2024
- NCT06298266Sponsor investigatorEarly Phase 1Mar 29, 2024
- NCT06298266Lead sponsorEarly Phase 1Mar 29, 2024
- NCT06298266OfficialEarly Phase 1Mar 29, 2024
- NCT06045585Reponsible party - principal investigatorEarly Phase 1Aug 18, 2023
- NCT06045585Lead sponsorEarly Phase 1Aug 18, 2023
- NCT06045585Overall official - principal investigatorEarly Phase 1Aug 18, 2023
- NCT05604755CollaboratorPhase 2Jan 1, 2022
- NCT04028323CollaboratorPhase 4Jul 16, 2019
- NCT00548223CollaboratorPhase 4Dec 1, 2007
Details
- Last known activity
- Feb 28, 2025